LEXICON PHARMACEUTICALS INC's ticker is LXRX and the CUSIP is 528872302. A total of 125 filers reported holding LEXICON PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 3.94 and the average weighting 0.9%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $128,133 | -52.4% | 117,553,284 | 0.0% | 5.49% | -34.1% |
Q2 2023 | $269,197 | +23.4% | 117,553,284 | +30.9% | 8.34% | -35.6% |
Q1 2023 | $218,161 | +27.2% | 89,778,234 | 0.0% | 12.96% | +35.4% |
Q4 2022 | $171,476 | -99.9% | 89,778,234 | 0.0% | 9.57% | +4.1% |
Q3 2022 | $215,468,000 | +62.8% | 89,778,234 | +26.1% | 9.20% | +30.1% |
Q2 2022 | $132,392,000 | -11.0% | 71,178,364 | 0.0% | 7.07% | +13.5% |
Q1 2022 | $148,763,000 | -47.0% | 71,178,364 | 0.0% | 6.23% | -18.2% |
Q4 2021 | $280,443,000 | -18.1% | 71,178,364 | 0.0% | 7.61% | -0.7% |
Q3 2021 | $342,368,000 | +4.8% | 71,178,364 | 0.0% | 7.66% | +15.5% |
Q2 2021 | $326,708,000 | -21.8% | 71,178,364 | 0.0% | 6.63% | -10.2% |
Q1 2021 | $417,817,000 | +71.6% | 71,178,364 | 0.0% | 7.38% | +41.3% |
Q4 2020 | $243,430,000 | +180.6% | 71,178,364 | +18.2% | 5.23% | +148.1% |
Q3 2020 | $86,746,000 | -27.8% | 60,240,864 | 0.0% | 2.11% | -37.4% |
Q2 2020 | $120,181,000 | +2.3% | 60,240,864 | 0.0% | 3.36% | -32.3% |
Q1 2020 | $117,470,000 | -53.0% | 60,240,864 | 0.0% | 4.96% | -48.6% |
Q4 2019 | $249,999,000 | +37.9% | 60,240,864 | 0.0% | 9.66% | +32.8% |
Q3 2019 | $181,325,000 | -52.1% | 60,240,864 | 0.0% | 7.27% | -52.6% |
Q2 2019 | $378,915,000 | +13.1% | 60,240,864 | 0.0% | 15.32% | +12.0% |
Q1 2019 | $334,939,000 | -16.3% | 60,240,864 | 0.0% | 13.68% | -7.7% |
Q4 2018 | $400,000,000 | -37.8% | 60,240,864 | 0.0% | 14.82% | -11.4% |
Q3 2018 | $642,770,000 | -11.1% | 60,240,864 | 0.0% | 16.72% | +8.8% |
Q2 2018 | $722,891,000 | +44.7% | 60,240,864 | +3.4% | 15.36% | +145.8% |
Q1 2018 | $499,413,000 | -13.3% | 58,274,650 | 0.0% | 6.25% | -28.0% |
Q4 2017 | $575,754,000 | -18.6% | 58,274,650 | +1.3% | 8.68% | -28.7% |
Q3 2017 | $706,896,000 | -25.3% | 57,517,977 | 0.0% | 12.18% | -26.3% |
Q2 2017 | $946,170,000 | +14.7% | 57,517,977 | 0.0% | 16.53% | -9.7% |
Q1 2017 | $824,807,000 | +3.7% | 57,517,977 | 0.0% | 18.31% | +3.7% |
Q4 2016 | $795,474,000 | -23.5% | 57,517,977 | 0.0% | 17.66% | -14.2% |
Q3 2016 | $1,039,349,000 | +25.9% | 57,517,977 | 0.0% | 20.58% | +20.8% |
Q2 2016 | $825,383,000 | +20.1% | 57,517,977 | 0.0% | 17.04% | +27.1% |
Q1 2016 | $687,340,000 | -10.2% | 57,517,977 | 0.0% | 13.41% | -6.7% |
Q4 2015 | $765,564,000 | +23.9% | 57,517,977 | -0.0% | 14.37% | +4.1% |
Q3 2015 | $617,743,000 | +33.4% | 57,517,978 | 0.0% | 13.80% | -30.7% |
Q2 2015 | $463,019,000 | – | 57,517,978 | – | 19.93% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ulys, L.L.C. | 4,321,214 | $71,084,000 | 100.00% |
Artal Group S.A. | 57,517,977 | $946,170,000 | 16.53% |
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 35,714 | $587,000 | 1.74% |
SECTOR GAMMA AS | 622,655 | $10,243,000 | 1.49% |
NEA Management Company, LLC | 2,382,286 | $39,189,000 | 1.43% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 606,410 | $9,975,000 | 0.68% |
MOODY ALDRICH PARTNERS LLC | 30,930 | $509,000 | 0.64% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 499,200 | $8,212,000 | 0.56% |
USS Investment Management Ltd | 3,507,900 | $57,705,000 | 0.54% |
Rock Springs Capital Management LP | 393,500 | $6,473,000 | 0.33% |